Inovio Pharmaceuticals, Inc. Guru Stock Analysis

INO 
$0.7125
*  
0.0345
  negative  
5.09%
Get INO Alerts
*Delayed - data as of May 21, 2013 13:28 ET 
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    INO Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored

The table below shows how INOVIO PHARMACEUTICALS INC (INO) fares using the theories of Peter Lynch, Benjamin Graham and other stock-picking legends, based on Validea's interpretation.

Looking for other stock ideas? Check out the full Guru Screener or try the Premium Guru Tools


Guru Rating

Scorecard


P/E Growth Investor Peter Lynch

INO gets a 0% rating based on Peter Lynch's methodology.
Detailed analysis of INO by Peter Lynch
0%
Detailed Analysis

Value Investor Benjamin Graham

INO gets a 29% rating based on Benjamin Graham's methodology.
Detailed analysis of INO by Benjamin Graham
29%
Detailed Analysis

Momentum Strategy Investor Validea

INO gets a 7% rating based on Validea Momentum methodology.
Detailed analysis of INO by Validea Momentum
7%
Detailed Analysis

Growth/Value Investor James O'Shaughnessy

INO gets a 0% rating based on James O'Shaughnessy's methodology.
Detailed analysis of INO by James O'Shaughnessy
0%
Detailed Analysis

Small Cap Growth Investor Motley Fool

INO gets a 32% rating based on Motley Fool's methodology.
Detailed analysis of INO by Motley Fool
32%
Detailed Analysis

Contrarian Investor David Dreman

INO gets a 14% rating based on David Dreman's methodology.
Detailed analysis of INO by David Dreman
14%
Detailed Analysis

Growth/Value Investor Martin Zweig

INO gets a 15% rating based on Martin Zweig's methodology.
Detailed analysis of INO by Martin Zweig
15%
Detailed Analysis

Price/Sales Investor Kenneth Fisher

INO gets a 40% rating based on Kenneth Fisher's methodology.
Detailed analysis of INO by Kenneth Fisher
40%
Detailed Analysis

  The names of individual investment advisors (i.e., the 'gurus') appearing ON THIS WEBSITE are for identification purposes ONLY. The names are used to identify the methodology as derived from the guru�s published sources. The names of the individual gurus are not intended to suggest or imply any affiliation with or endorsement of, or even any agreement with the information displayed on this website personally by such gurus, or any knowledge or approval by such persons of the content on this website. All trademarks, service marks and trade names appearing on this website are the property of their respective owners, and are likewise used for identification purposes only.
  The NASDAQ Stock Market, Inc. ("NASDAQ"), its affiliates, third party information providers, or any of these entities� officers, employees, directors, or agents have not: (1) passed on the merit of the information provided on this website or on any of these securities; or (2) endorsed or sponsored any of these securities. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. The information contained on this website is provided for informational purposes only. See Full Disclaimer Below
See Full Disclaimer


Create your free portfolio